Clinical Trial Update: An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC [Phase 2]

View source ↗

Summary

Phase 2 exploratory study investigating herombopag for chemotherapy-induced thrombocytopenia in non-small cell lung cancer treated with immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN